Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer’s disease mice

Autophagy: Renovation of Cells and Tissues

Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,467 · see citing works

Global prevalence of dementia: a Delphi consensus study

Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336 · see citing works

The global prevalence of dementia: a systematic review and metaanalysis.

Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941 · see citing works

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles

Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126 · see citing works

The role of autophagy in neurodegenerative disease

Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059 · see citing works

Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis

Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357 · see citing works

Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice

Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294 · see citing works

The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice.

Pickford, F., Masliah, E., Britschgi, M., Lucin, K. M., Narasimhan, R., Jaeger, P. A., Small, S., Spencer, B., Rockenstein, E., Levine, B., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33585 · Cited by 1,186 · see citing works

Cerebral microvascular pathology in aging and Alzheimer's disease

Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · see citing works

Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau

Caccamo, A., Majumder, S., Richardson, A., Strong, R., & Oddo, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100420 · Cited by 881 · see citing works

Permanent, bilateral common carotid artery occlusion in the rat: A model for chronic cerebral hypoperfusion-related neurodegenerative diseases

Farkas, E., Luiten, P. G. M., & Bari, F. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.01.003 · Cited by 724 · see citing works

Autophagy failure in Alzheimer's disease—locating the primary defect

Nixon, R. A., & Yang, D. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.021 · Cited by 634 · see citing works

Autophagy and aging: keeping that old broom working

Cuervo, A. M. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.10.002 · Cited by 527 · see citing works

Overlap Between Pathology of Alzheimer Disease and Vascular Dementia

Kalaria, R. N., & Ballard, C. G. (1999) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199912003-00017 · Cited by 472 · see citing works

Autophagy failure in A lzheimer's disease and the role of defective lysosomal acidification

Wolfe, D. M., Lee, J., Kumar, A. R., Lee, S., Orenstein, S. J., & Nixon, R. A. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12169 · Cited by 348 · see citing works

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly

Vemuri, P., Lesnick, T. G., Przybelski, S. A., Knopman, D. S., Preboske, G. M., Kantarci, K., Raman, M. R., Machulda, M. M., Mielke, M. M., Lowe, V. J., et al. (2015) · Brain · doi:10.1093/brain/awu393 · Cited by 299 · see citing works

Tau Aggregation Inhibitor Therapy: An Exploratory Phase 2 Study in Mild or Moderate Alzheimer's Disease

Wischik, C. M., Staff, R. T., Wischik, D. J., Bentham, P., Murray, A. D., Storey, J. M. D., Kook, K. A., & Harrington, C. R. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142874 · Cited by 269 · see citing works

The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT

Hirao, K., Ohnishi, T., Hirata, Y., Yamashita, F., Mori, T., Moriguchi, Y., Matsuda, H., Nemoto, K., Imabayashi, E., Yamada, M., et al. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.06.066 · Cited by 260 · see citing works

Vascular Basis of Alzheimer's Pathogenesis

de la Torre, J. C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04817.x · Cited by 236 · see citing works

Cerebral blood flow and metabolic abnormalities in Alzheimer’s disease

Matsuda, H. (2001) · Annals of Nuclear Medicine · doi:10.1007/bf02988596 · Cited by 233 · see citing works

Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors

Jiang, T., Yu, J., Tian, Y., & Tan, L. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990155 · Cited by 224 · see citing works

Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy

Tan, C., Yu, J., Tan, M., Jiang, T., Zhu, X., & Tan, L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.019 · Cited by 221 · see citing works

Alzheimer's therapeutics: Continued clinical failures question the validity of the amyloid hypothesis—but what lies beyond?

Mullane, K., & Williams, M. J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.11.014 · Cited by 212 · see citing works

Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat

Wakita, H., Tomimoto, H., Akiguchi, I., Matsuo, A., Lin, J.-X., Ihara, M., & McGeer, P.-L. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03223-1 · Cited by 197 · see citing works

Brain Lesions at Autopsy in Older Japanese-American Men as Related to Cognitive Impairment and Dementia in the Final Years of Life: A Summary Report from the Honolulu-Asia Aging Study

White, L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1178 · Cited by 193 · see citing works

Chronic cerebral hypoperfusion induced by right unilateral common carotid artery occlusion causes delayed white matter lesions and cognitive impairment in adult mice

Yoshizaki, K., Adachi, K., Kataoka, S., Watanabe, A., Tabira, T., Takahashi, K., & Wakita, H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.12.005 · Cited by 190 · see citing works

From Chronic Cerebral Hypoperfusion to Alzheimer-Like Brain Pathology and Neurodegeneration

Zhao, Y., & Gong, C.-X. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0127-9 · Cited by 180 · see citing works

Autophagy and Neuronal Cell Death in Neurological DisordersPreprint

Nixon, R. A., & Yang, D.-S. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008839 · Cited by 179 · see citing works

Coevolution of white matter hyperintensities and cognition in the elderly

Maillard, P., Carmichael, O., Fletcher, E., Reed, B., Mungas, D., & DeCarli, C. (2012) · Neurology · doi:10.1212/wnl.0b013e3182617136 · Cited by 172 · see citing works

mTOR's role in ageing: protein synthesis or autophagy?

Hands, S. L., Proud, C. G., & Wyttenbach, A. (2009) · Aging · doi:10.18632/aging.100070 · Cited by 159 · see citing works

Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD

Borroni, B., Anchisi, D., Paghera, B., Vicini, B., Kerrouche, N., Garibotto, V., Terzi, A., Vignolo, L. A., Luca, M. D., Giubbini, R., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.12.010 · Cited by 156 · see citing works

Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein

Wen, Y., Yang, S., Liu, R., & Simpkins, J. W. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.106 · Cited by 149 · see citing works

Autophagy and protein aggregation after brain ischemia

Liu, C., Gao, Y.-Q., Barrett, J., & Hu, B.-R. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06905.x · Cited by 132 · see citing works

The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment

Tosto, G., Zimmerman, M. E., Hamilton, J. L., Carmichael, O. T., Brickman, A. M., & Initiative, A. D. N. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.014 · Cited by 112 · see citing works

Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion

Bennett, S. A. L., Pappas, B. A., Stevens, W. D., Davidson, C. M., Fortin, T., & Chen, J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00131-7 · Cited by 110 · see citing works

Effect of Vascular Lesions on Cognition in Alzheimer's Disease: A Community‐Based Study

Riekse, R. G., Leverenz, J. B., McCormick, W. C., Bowen, J. D., Teri, L. L., Nochlin, D., Simpson, K., Eugenio, C. J., Larson, E. B., & Tsuang, D. W. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52405.x · Cited by 109 · see citing works

Chronic cerebral hypoperfusion accelerates amyloid β deposition in APPSwInd transgenic mice

Kitaguchi, H., Tomimoto, H., Ihara, M., Shibata, M., Uemura, K., Kalaria, R. N., Kihara, T., Asada-Utsugi, M., Kinoshita, A., & Takahashi, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.078 · Cited by 108 · see citing works

Chronic cerebral hypoperfusion causes decrease of O-GlcNAcylation, hyperphosphorylation of tau and behavioral deficits in mice

Yang, Z., Gu, J., Dai, C., Liu, Q., Iqbal, K., Liu, F., & Gong, C. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00010 · Cited by 100 · see citing works

Beclin 1 Complex in Autophagy and Alzheimer Disease

Jaeger, P. A., & Wyss‐Coray, T. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.258 · Cited by 90 · see citing works

Chronic Mild Reduction of Cerebral Perfusion Pressure Induces Ischemic Tolerance in Focal Cerebral Ischemia

Kitagawa, K., Yagita, Y., Sasaki, T., Sugiura, S., Omura‐Matsuoka, E., Mabuchi, T., Matsushita, K., & Hori, M. (2005) · Stroke · doi:10.1161/01.str.0000181075.77897.0e · Cited by 72 · see citing works

The levels of water-soluble and triton-soluble Aβ are increased in Alzheimer's disease brain

McDonald, J. M., Cairns, N. J., Taylor‐Reinwald, L., Holtzman, D. M., & Walsh, D. M. (2012) · Brain Research · doi:10.1016/j.brainres.2012.02.041 · Cited by 60 · see citing works

Neurobehavioral and Imaging Correlates of Hippocampal Atrophy in a Mouse Model of Vascular Cognitive Impairment

Zuloaga, K. L., Zhang, W. H., Yeiser, L. A., Stewart, B., Kukino, A., Nie, X. J., Roese, N. E., Grafe, M. R., Pike, M. M., Raber, J., et al. (2015) · Translational Stroke Research · doi:10.1007/s12975-015-0412-z · Cited by 56 · see citing works

Interplay Between Age, Cerebral Small Vessel Disease, Parenchymal Amyloid-β, and Tau Pathology: Longitudinal Studies in Hypertensive Stroke-Prone Rats

Schreiber, S., Drukarch, B., Garz, C., Niklass, S., Stanaszek, L., Kropf, S., Bueche, C. Z., Held, F., Vielhaber, S., Attems, J., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132618 · Cited by 53 · see citing works

mTOR Inhibition: From Aging to Autism and Beyond

Kaeberlein, M. R. (2013) · Scientifica · doi:10.1155/2013/849186 · Cited by 51 · see citing works

Clinical significance of subcortical vascular disease in patients with mild cognitive impairment

de Mendonça, A., Ribeiro, F., Guerreiro, M., Palma, T., & García, C. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00892.x · Cited by 45 · see citing works

Progression of cerebral white matter lesions in Alzheimer's disease: a new window for therapy?

de Leeuw, F.-E. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.053686 · Cited by 45 · see citing works

Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease

Kandiah, N., Chander, R. J., Ng, A. Y. T., Wen, M., Cenina, A. R., & Assam, P. N. (2014) · European Journal of Neurology · doi:10.1111/ene.12546 · Cited by 38 · see citing works

Comparative analysis of autophagy and tauopathy related markers in cerebral ischemia and Alzheimer’s disease animal models

Villamil-Ortiz, J. G., & Cardona‐Gómez, G. P. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00084 · Cited by 28 · see citing works

The role of autophagic and lysosomal pathways in ischemic brain injury.

Gu, Z., Sun, Y., Liu, K., Wang, F., Zhang, T., Li, Q., Shen, L., Ling, Z., Dong, L., Shi, N., et al. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.23.001 · Cited by 13 · see citing works

Synergy between amyloid-β and tau in Alzheimer’s disease

Busche, M. A., & Hyman, B. T. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0687-6 · Cited by 1,242 · see citing works

Tau PET imaging in neurodegenerative tauopathies—still a challenge

Leuzy, A., Chiotis, K., Lemoine, L., Gillberg, P.-G., Almkvist, O., Rodriguez-Vieitez, E., & Nordberg, A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0342-8 · Cited by 628 · see citing works

Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease

Korte, N., Nortley, R., & Attwell, D. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02215-w · Cited by 343 · see citing works

The microbiota-gut-brain axis participates in chronic cerebral hypoperfusion by disrupting the metabolism of short-chain fatty acids

Xiao, W., Su, J., Gao, X., Yang, H., Weng, R., Ni, W., & Gu, Y. (2022) · Microbiome · doi:10.1186/s40168-022-01255-6 · Cited by 252 · see citing works

Dietary salt promotes cognitive impairment through tau phosphorylation

Faraco, G., Hochrainer, K., Segarra, S. G., Schaeffer, S., Santisteban, M. M., Menon, A., Jiang, H., Holtzman, D. M., Anrather, J., & Iadecola, C. (2019) · Nature · doi:10.1038/s41586-019-1688-z · Cited by 236 · see citing works

Cognitive impact of COVID-19: looking beyond the short term

Miners, J. S., Kehoe, P. G., & Love, S. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00744-w · Cited by 248 · see citing works

Animal Models of Chronic Cerebral Hypoperfusion: From Mouse to Primate

Washida, K., Hattori, Y., & Ihara, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246176 · Cited by 166 · see citing works

High-fat diet exacerbates cognitive decline in mouse models of Alzheimer's disease and mixed dementia in a sex-dependent manner

Gannon, O. J., Robison, L. S., Salinero, A. E., Abi-Ghanem, C., Mansour, F. M., Kelly, R. D., Tyagi, A., Brawley, R. R., Ogg, J. D., & Zuloaga, K. L. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02466-2 · Cited by 127 · see citing works

Causes and consequences of baseline cerebral blood flow reductions in Alzheimer’s disease

Bracko, O., Hernández, J. C. C., Park, L., Nishimura, N., & Schaffer, C. B. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20982383 · Cited by 122 · see citing works

An Integrated View on Vascular Dysfunction in Alzheimer’s Disease

Klohs, J. (2019) · Neurodegenerative Diseases · doi:10.1159/000505625 · Cited by 111 · see citing works

The Glymphatic System: A Novel Therapeutic Target for Stroke Treatment

Lv, T., Zhao, B., Hu, Q., & Zhang, X. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.689098 · Cited by 105 · see citing works

Cardiac Contributions to Brain Health: A Scientific Statement From the American Heart Association

Testai, F. D., Gorelick, P. B., Chuang, P., Dai, X., Furie, K. L., Gottesman, R. F., Iturrizaga, J. C., Lazar, R. M., Russo, A. M., Seshadri, S. S., et al. (2024) · Stroke · doi:10.1161/str.0000000000000476 · Cited by 106 · see citing works

Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18 F-AV1451 Positron Emission Tomography Imaging

Kim, Y. J., Park, S., Cho, H., Jang, Y. K., Lee, J. S., Jang, H., Kim, Y., Kim, K. W., Ryu, Y. H., Choi, J. Y., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0975 · Cited by 101 · see citing works

The effect of chronic cerebral hypoperfusion on the pathology of Alzheimer's disease: A positron emission tomography study in rats

Park, J., Hong, J., Lee, S., Ji, H. D., Jung, J.-A., Yoon, K.-W., Lee, J.-I., Won, K. S., Song, B., & Kim, H. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-50681-4 · Cited by 96 · see citing works

Regulatory effects of autophagy on spermatogenesis

Yin, J., Ni, B., Tian, Z., Yang, F., Liao, W.-G., & Gao, Y. (2017) · Biology of Reproduction · doi:10.1095/biolreprod.116.144063 · Cited by 89 · see citing works

Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid

Albrecht, D., Isenberg, A. L., Stradford, J., Monreal, T. K., Sagare, A. P., Pachicano, M., Sweeney, M. D., Toga, A. W., Zloković, B. V., Chui, H. C., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1230-20.2020 · Cited by 85 · see citing works

Pathological Impacts of Chronic Hypoxia on Alzheimer’s Disease

Zhang, F., Niu, L., Li, S., & Le, W. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00442 · Cited by 80 · see citing works

The contribution of β-amyloid, Tau and α-synuclein to blood–brain barrier damage in neurodegenerative disorders

Wu, Y., Bogale, T. A., Koıstınaho, J., Pizzi, M., Rõlova, T., & Bellucci, A. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02696-z · Cited by 81 · see citing works

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease

Bryant, A. G., Hu, M., Carlyle, B. C., Arnold, S. E., Frosch, M. P., Das, S., Hyman, B. T., & Bennett, R. E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.575953 · Cited by 79 · see citing works

Small Vessels Are a Big Problem in Neurodegeneration and Neuroprotection

Erdener, Ş. E., & Dalkara, T. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00889 · Cited by 76 · see citing works

Cerebral Hypoperfusion and Other Shared Brain Pathologies in Ischemic Stroke and Alzheimer’s Disease

Dong, S., Maniar, S., Manole, M. D., & Sun, D. (2017) · Translational Stroke Research · doi:10.1007/s12975-017-0570-2 · Cited by 69 · see citing works

Inhibition of excessive autophagy and mitophagy mediates neuroprotective effects of URB597 against chronic cerebral hypoperfusion

Su, S.-H., Wu, Y., Wang, D., & Hai, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0755-y · Cited by 70 · see citing works

Hypoxia-Induced Signaling Activation in Neurodegenerative Diseases: Targets for New Therapeutic Strategies

Jha, N. K., Jha, S. K., Sharma, R. R., Kumar, D., Ambasta, R. K., & Kumar, P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170589 · Cited by 62 · see citing works

Progress of RAGE Molecular Imaging in Alzheimer’s Disease

Kong, Y., Liu, C., Zhou, Y., Qi, J., Zhang, C., Sun, B., Wang, J., & Guan, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00227 · Cited by 61 · see citing works

Hypertension is associated with worse cognitive function and hippocampal hypometabolism in Alzheimer's disease

Moonga, I., Niccolini, F., Wilson, H., Pagano, G., Politis, M., & Initiative, T. A. D. N. (2017) · European Journal of Neurology · doi:10.1111/ene.13374 · Cited by 58 · see citing works

Association of Aortic Stiffness With Biomarkers of Neuroinflammation, Synaptic Dysfunction, and Neurodegeneration

Moore, E. E., Liu, D., Li, J., Schimmel, S. J., Cambronero, F. E., Terry, J. G., Nair, S., Pechman, K. R., Moore, M. E., Bell, S. P., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012257 · Cited by 56 · see citing works

Signs of ROS-Associated Autophagy in Testis and Sperm in a Rat Model of Varicocele

Sadeghi, N., Erfani-Majd, N., Tavalaee, M., Tabandeh, M. R., Drevet, J. R., & Nasr‐Esfahani, M. H. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5140383 · Cited by 52 · see citing works

Cerebral perfusion alterations in type 2 diabetes mellitus – a systematic review

Wang, Y., Sun, L., He, G., Gang, X., Zhao, X. Y., Wang, G., & Ning, G. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100916 · Cited by 49 · see citing works

Association of Aortic Stiffness and Pressure Pulsatility With Global Amyloid-β and Regional Tau Burden Among Framingham Heart Study Participants Without Dementia

Cooper, L. L., O’Donnell, A., Beiser, A., Thibault, E. G., Sanchez, J. S., Benjamin, E. J., Hamburg, N. M., Vasan, R. S., Larson, M. G., Johnson, K. A., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.1261 · Cited by 43 · see citing works

Oxidative stress and chronic cerebral hypoperfusion: An overview from preclinical rodent models

Kimura, S., Iwata, M., Takase, H., Lo, E. H., & Arai, K. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241305899 · Cited by 44 · see citing works

CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice

Bhargavan, B., Woollard, S. M., Mcmillan, J. E. M., & Kanmogne, G. D. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00500-0 · Cited by 43 · see citing works

URB597 improves cognitive impairment induced by chronic cerebral hypoperfusion by inhibiting mTOR-dependent autophagy

Wang, D., Lin, Q. D., Su, S., Liu, K., Wu, Y., & Hai, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.12.034 · Cited by 41 · see citing works

Impact of the biological definition of Alzheimer’s disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?

Gauthier, S. G., Zhang, H., Ng, K. P., Pascoal, T. A., & Rosa‐Neto, P. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0117-9 · Cited by 40 · see citing works

Characterization of Tauopathy in a Rat Model of Post-Stroke Dementia Combining Acute Infarct and Chronic Cerebral Hypoperfusion

Back, D. B., Choi, B., Han, J., Kwon, K. J., Choi, D., Shin, C. Y., Lee, J., & Kim, H. Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186929 · Cited by 38 · see citing works

Ambiguous Effects of Autophagy Activation Following Hypoperfusion/Ischemia

Ferrucci, M., Biagioni, F., Ryskalin, L., Limanaqi, F., Gambardella, S., Frati, A., & Fornai, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092756 · Cited by 36 · see citing works

Alzheimer’s associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia

Nguyen, T. V., Hayes, M. I., Zbesko, J. C., Frye, J. B., Congrove, N. R., Belichenko, N. P., McKay, B. S., Longo, F. M., & Doyle, K. P. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0603-4 · Cited by 34 · see citing works

EGB761 ameliorates chronic cerebral hypoperfusion-induced cognitive dysfunction and synaptic plasticity impairment

Yao, Z., Wang, J., Yuan, J., Xiao, K., Zhang, S., Xie, Y., & Mei, J. (2021) · Aging · doi:10.18632/aging.202555 · Cited by 34 · see citing works

Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?

Tarawneh, R. (2023) · Biomolecules · doi:10.3390/biom13050830 · Cited by 29 · see citing works

Endothelial Senescence and Its Impact on Angiogenesis in Alzheimer’s Disease

Georgieva, I., Tchekalarova, J. D., Iliev, D. B., & Tzoneva, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411344 · Cited by 29 · see citing works

Impairments in Brain Bioenergetics in Aging and Tau Pathology: A Chicken and Egg Situation?

Grimm, A. (2021) · Cells · doi:10.3390/cells10102531 · Cited by 28 · see citing works

Friend or foe: role of pathological tau in neuronal death

Wu, M., Chen, Z., Jiang, M. H., Bao, B., Li, D., Yin, X., Wang, X., Liu, D., & Zhu, L. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02024-z · Cited by 28 · see citing works

HIF-1α serves as a co-linker between AD and T2DM

Yang, H. T., Ren, K., Zhang, Y., Yang, L., Cao, H., Yuan, X., Su, L., Li, H., Feng, X., & Liu, D. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116158 · Cited by 26 · see citing works

Metabolic Risk Factors of Alzheimer’s Disease, Dementia with Lewy Bodies, and Normal Elderly: A Population-Based Study

Cheng, C.-K., Tsao, Y., Su, Y., Sung, F., Tai, H.-C., & Kung, W. (2018) · Behavioural Neurology · doi:10.1155/2018/8312346 · Cited by 29 · see citing works

Challenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors

Kuo, Y., & Rajesh, R. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1621750 · Cited by 26 · see citing works

Deciphering Alzheimer’s Disease Pathogenic Pathway: Role of Chronic Brain Hypoperfusion on p-Tau and mTOR

de la Torre, J. C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201165 · Cited by 26 · see citing works

Preservation of spatial memory and neuroprotection by the fatty acid amide hydrolase inhibitor URB597 in a rat model of vascular dementia

Wang, D., Lin, Q. D., Kang, K., Wu, Y., Su, S., & Hai, J. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-4431 · Cited by 24 · see citing works

Elevated plasma sulfides are associated with cognitive dysfunction and brain atrophy in human Alzheimer's disease and related dementias

Reekes, T. H., Ledbetter, C. R., Alexander, J., Stokes, K. Y., Pardue, S., Bhuiyan, M. A. N., Patterson, J. C., Lofton, K. T., Kevil, C. G., & Disbrow, E. A. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102633 · Cited by 26 · see citing works

The potential protective effects of cannabinoid receptor agonist WIN55,212-2 on cognitive dysfunction is associated with the suppression of autophagy and inflammation in an experimental model of vascular dementia

Wang, D., Yin, H., Kang, K., Lin, Q. D., Su, S., & Hai, J. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.06.012 · Cited by 27 · see citing works

Cerebrovascular alterations in NAFLD: Is it increasing our risk of Alzheimer's disease?

Hadjihambi, A. (2021) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114387 · Cited by 24 · see citing works

Glucagon-Like Peptide-2 Receptor is Involved in Spatial Cognitive Dysfunction in Rats After Chronic Cerebral Hypoperfusion

Xie, Y.-C., Yao, Z.-H., Yao, X.-L., Pan, J.-Z., Zhang, S.-F., Zhang, Y., & Hu, J.-C. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180782 · Cited by 24 · see citing works

Hypoperfusion is a potential inducer of immunosuppressive network in Alzheimer's disease

Salminen, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104919 · Cited by 20 · see citing works

Shengyu Decoction treating vascular cognitive impairment by promoting AKT/HIF-1α/VEGF related cerebrovascular generation and ameliorating MAPK/NF-κB mediated neuroinflammation

Fang, C., Liu, J., Feng, M., Jia, Z., Li, Y., Dai, Y., Zhu, M., Huang, B., Liu, L., Wei, Z., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115441 · Cited by 20 · see citing works

Regulation of oxygen–glucose deprivation/reperfusion-induced inflammatory responses and M1-M2 phenotype switch of BV2 microglia by lobetyolin

wang, J., Liu, X., Wei, W., Yang, J., Li, Q., Chu, S., Liu, P., Zhang, J., & He, W. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01292-6 · Cited by 19 · see citing works

Chronic cerebral hypoperfusion upregulates leptin receptor expression in astrocytes and tau phosphorylation in tau transgenic mice

Shimada, T., Shindo, A., Matsuyama, H., Yata, K., Niwa, A., Sasaki, R., Ayaki, T., Maki, T., Wakita, H., & Tomimoto, H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.009 · Cited by 19 · see citing works

Intracerebroventricular injection of Aβ1-42 combined with two-vessel occlusion accelerate Alzheimer’s disease development in rats

Dai, S. J., Zhang, J. Y., Bao, Y. T., Zhou, X. J., Lin, L. N., Fu, Y. B., Zhang, Y. J., Li, C., & Yang, Y. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.07.020 · Cited by 18 · see citing works

Targeting TDP-43 Pathology Alleviates Cognitive and Motor Deficits Caused by Chronic Cerebral Hypoperfusion

Thammisetty, S. S., Renaud, L., Picher‐Martel, V., Weng, Y. C., Calon, F., Saïkali, S., Julien, J., & Križ, J. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01015-8 · Cited by 18 · see citing works

Neuroprotection Targeting Protein Misfolding on Chronic Cerebral Hypoperfusion in the Context of Metabolic Syndrome

Herrera, M. I., Udovin, L., Toro-Urrego, N., Kusnier, C. F., Luaces, J. P., Losada, M. E. O., & Capani, F. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00339 · Cited by 18 · see citing works

Sex and APOE ɛ4 modify the effect of cardiovascular risk on tau in cognitively normal older adults

Tsiknia, A. A., Reas, E. T., Bangen, K. J., Sundermann, E. E., McEvoy, L. K., Brewer, J. B., Edland, S. D., Banks, S. J., & Initiative, A. D. N. (2022) · Brain Communications · doi:10.1093/braincomms/fcac035 · Cited by 17 · see citing works

Persistent therapeutic effect of a novel α5-GABAA receptor antagonist in rodent preclinical models of vascular cognitive impairment

Gacsályi, I., Móricz, K., Gigler, G., Megyeri, K., Machado, P., & Antoni, F. A. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.015 · Cited by 17 · see citing works

Extracranial carotid atherosclerosis is associated with increased neurofibrillary tangle accumulation

Arias, J. C., Edwards, M., Vitali, F., Beach, T. G., Serrano, G. E., & Weinkauf, C. C. (2021) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2021.07.238 · Cited by 15 · see citing works

Impact of adverse pregnancy outcomes on brain vascular health and cognition

Wolfová, K., & Miller, E. C. (2024) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2024.102331 · Cited by 15 · see citing works

Oxygen Sensing and Signaling in Alzheimer’s Disease: A Breathtaking Story!

Correia, S. C., & Moreira, P. I. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01148-6 · Cited by 14 · see citing works

cPKCγ Deficiency Exacerbates Autophagy Impairment and Hyperphosphorylated Tau Buildup through the AMPK/mTOR Pathway in Mice with Type 1 Diabetes Mellitus

Zheng, J., Wang, Y., Liu, Y., Han, S., Zhang, Y., Luo, Y., Yan, Y., Li, J., & Zhao, L. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00863-4 · Cited by 14 · see citing works

Medial Temporal Atrophy in Amyloid-Negative Amnestic Type Dementia Is Associated with High Cerebral White Matter Hyperintensity

Wong, B. Y. X., Yong, T. T., Lim, L., Tan, J. Y., Ng, A. S. L., Ting, S. K. S., Hameed, S., Ng, K. P., Zhou, J. H., & Kandiah, N. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181261 · Cited by 13 · see citing works

Aberrant vascular architecture in the hippocampus correlates with tau burden in mild cognitive impairment and Alzheimer’s disease

Lee, H., Fu, J. F., Gaudet, K., Bryant, A. G., Price, J. C., Bennett, R. E., Johnson, K. A., Hyman, B. T., Hedden, T., Salat, D. H., et al. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231216144 · Cited by 11 · see citing works

Association of Low Systolic Blood Pressure with Postmortem Amyloid-β and Tau

Oveisgharan, S., Capuano, A. W., Kapasi, A., Buchman, A. S., Schneider, J. A., Bennett, D. A., & Arvanitakis, Z. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200412 · Cited by 11 · see citing works

Impaired Kv7 channel function in cerebral arteries of a tauopathy mouse model ( rT g4510)

de Jong, I. E. M., & Jepps, T. A. (2018) · Physiological Reports · doi:10.14814/phy2.13920 · Cited by 11 · see citing works

Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer’s disease through machine learning algorithms

Jiang, L., Wang, Q., Jiang, Y., Peng, D., Zong, K., Li, S., Xie, W., Zhang, C., Li, K., Wu, Z., et al. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.117892 · Cited by 10 · see citing works

Cardiovascular Response to Mental Stress in Mild Cognitive Impairment and its Association with Cerebral Perfusion

Henley, B., Shokouhi, M., Mahajan, A. Y., Inan, O. T., & Hajjar, I. M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180036 · Cited by 10 · see citing works

Combination of indirect revascularization and endothelial progenitor cell transplantation improved cerebral perfusion and ameliorated tauopathy in a rat model of bilateral ICA ligation

Wang, K., Yang, L., Lee, J., Wu, V., Chen, T.-F., Hsieh, S., & Kuo, M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03196-1 · Cited by 10 · see citing works

Hypoperfusion Precedes Tau Deposition in the Entorhinal Cortex: A Retrospective Evaluation of ADNI-2 Data

Kapadia, A. N., Bilimoria, K., Desai, P., Grist, J. T., Heyn, C., Maralani, P. J., Symons, S. P., & Zaccagna, F. (2023) · Journal of Clinical Neurology · doi:10.3988/jcn.2022.0088 · Cited by 9 · see citing works

The therapeutic effects and mechanisms of glucagon-like peptide-1 receptor agonists in neurocognitive disorders

Si, J., Yu, K., Hao, J., Wang, J., & Zhang, L. (2025) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864251332035 · Cited by 9 · see citing works

Roles of glutamate receptors in a novel in vitro model of early, comorbid cerebrovascular, and Alzheimer’s diseases

Pires, E. N. S., Ferreira, S. T., & Linden, R. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15129 · Cited by 9 · see citing works

Compound C enhances tau phosphorylation at Serine396 via PI3K activation in an AMPK and rapamycin independent way in differentiated SH-SY5Y cells

Majd, S., Koblar, S. A., & Power, J. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.01.049 · Cited by 9 · see citing works

Echocardiographic measures of the left heart and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: The CABLE study

Hu, H., Hu, H., Jiang, J., Bi, Y., Sun, Y. P., Ou, Y., Tan, L., & Yu, J. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13837 · Cited by 8 · see citing works

Effect of amyloid toxicity or chronic cerebral hypoperfusion on brain insulin resistance in a rat model with intracerebroventricular streptozotocin

Choi, B., Seo, J.-H., Back, D. B., Han, J., Choi, D., Kwon, K. J., Shin, C. Y., Lee, J., & Kim, H. Y. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.02.012 · Cited by 8 · see citing works

Role of soy lecithin combined with soy isoflavone on cerebral blood flow in rats of cognitive impairment and the primary screening of its optimum combination

Li, H., Wang, X., Li, X., Zhou, X., Wang, X., Xi, Y., Xiao, R., & Xi, Y. (2023) · Nutrition Research and Practice · doi:10.4162/nrp.2023.17.2.371 · Cited by 8 · see citing works

Arterial hypertension and Alzheimer’s disease. Prologue to neurodegeneration

Lobzin, V. Y., Kolmakova, K. A., Emelin, А. Y., & Yanishevskiy, S. N. (2019) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2019-25-2-122-133 · Cited by 7 · see citing works

Buyang Huanwu Decoction Modulates the Gut Microbiota–C/EBPβ/ AEP Axis to Ameliorate Cognitive Impairment in Alzheimer's Disease Mice

Liang, J., Dong, X., Yang, J., Hu, N., Luo, X., Cong, S., Chen, J., Zhao, W., & Liu, B. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70480 · Cited by 6 · see citing works

Heterogeneous Disease Progression in a Mouse Model of Vascular Cognitive Impairment

Lee, N. K., Kim, H., Yang, J., Kim, J., Son, J. P., Jang, H., & Na, D. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082820 · Cited by 6 · see citing works

Deep cerebral microbleeds are associated with poor cholinesterase inhibitor treatment response in people with Alzheimer disease

Chiu, W. T., Lee, T. Y., Chan, L., Wu, D., Huang, L. K., Chen, D. Y. T., Lee, Y. T., Hu, C. J., & Hong, C. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.105959 · Cited by 6 · see citing works

Long-Term Potentiation Enhances Neuronal Differentiation in the Chronic Hypoperfusion Model of Rats

Takeuchi, H., Kameda, M., Yasuhara, T., Sasaki, T., Toyoshima, A., Morimoto, J., Kin, K., Okazaki, M., Umakoshi, M., Kin, I., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00029 · Cited by 6 · see citing works

Blood Pressure Variability and Plasma Biomarkers of Neuronal Injury and Alzheimer’s Disease: A Clinic-Based Study of Patients with Diseases Along the Heart-Brain Axis

Starmans, N. L., Kappelle, L. J., Muller, M., Staals, J., Teunissen, C. E., Biessels, G. J., van der Flier, W. M., & Wolters, F. J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240119 · Cited by 5 · see citing works

Hypertension and Neuropsychiatric Symptoms in Patients with Drug-Naïve Alzheimer's Disease

Hwang, I., Baek, K. H., Han, J. H., Ha, S., & Yang, Y. (2017) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2017.16.3.78 · Cited by 5 · see citing works

Cerebral blood flow is associated with plasma and PET biomarkers of tau pathology in middle age

Houck, A. L., Alshikho, M. J., Lao, P. J., Pyne, J. D., Turney, I. C., Mazen, J., Benavides, A., Hale, C., Herman, M., Berroa, J., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf249 · Cited by 4 · see citing works

Exploring the vital role of microglial membrane receptors in Alzheimer’s disease pathogenesis: a comprehensive review

ZHAO, J.-F., JIANG, Y.-R., GUO, T.-L., JIAO, Y.-Q., & WANG, X. (2024) · Biocell · doi:10.32604/biocell.2024.050120 · Cited by 4 · see citing works

Multifactorial glial responses and their contributions to Alzheimer's disease continuum

Hijioka, M., Manabe, T., & Saito, T. (2023) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12745 · Cited by 4 · see citing works

Upregulation of RasGRF1 ameliorates spatial cognitive dysfunction in mice after chronic cerebral hypoperfusion

Yang, L., Wu, W., Jiang, W., Zhu, C., & Yao, Z. (2023) · Aging · doi:10.18632/aging.204654 · Cited by 4 · see citing works

Virus-mediated delivery of single-chain antibody targeting TDP-43 protects against neuropathology, cognitive impairment and motor deficit caused by chronic cerebral hypoperfusion

Chami, A. A., Gravel, C., Weng, Y. C., Križ, J., & Julien, J. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115138 · Cited by 4 · see citing works

Longitudinal relationships among cerebrospinal fluid biomarkers, cerebral blood flow, and grey matter volume in individuals with a familial history of Alzheimer's disease

Sanami, S., Intzandt, B., Huck, J., Villeneuve, S., Iturria‐Medina, Y., & Gauthier, C. J. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.04.011 · Cited by 3 · see citing works

White matter hyperintensity modulates the amyloid‐tau‐cognition association and anti‐amyloid treatment efficacy in asymptomatic older adults

Lin, Z., Hong, Y., Hu, Y., Xiao, Q., Peng, S., Wu, D., Guo, T., & Jiang, D. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70990 · Cited by 2 · see citing works

Autophagy-related biomarkers in non-obstructive azoospermia: insights from transcriptomics and single-cell sequencing

Yao, J., Zhang, Y., Lan, T., & Li, Y. (2025) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-025-03559-6 · Cited by 2 · see citing works

Diabetes and postoperative cognitive dysfunction and delirium in adults: mechanisms, biomarkers, and clinical management

Alwesabi, A. K., Ma, Y., Gao, B., Xie, J., Ji, C., Xiaodong, S., Fu, Q., Liu, Y., Liu, Q., Xie, J., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1745202 · Cited by 2 · see citing works

Elevated amyloid beta peptides and total tau in cerebrospinal fluid in individuals with Creatine transporter deficiency

Rahhal, S. N., Farmer, C., Thurm, A. E., Wassif, C. A., Cawley, N. X., Perreault, J., Do, A. N. D., Bianconi, S. E., Hannah‐Shmouni, F., Guthrie, W., et al. (2023) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2023.101001 · Cited by 2 · see citing works

Chronic Sustained Hypoxia Leads to Brainstem Tauopathy and Declines the Power of Rhythms in the Ventrolateral Medulla: Shedding Light on a Possible Mechanism

Khalilpour, J., Zangbar, H. S., Alipour, M. R., Pakdel, F. Q., Zavari, Z., & Shahabi, P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03763-4 · Cited by 2 · see citing works

Prolonged Chronic Cerebral Hypoperfusion Does not Exacerbate Tau Pathology in a Tauopathy Mouse Model

Lee, N. K., Na, D. L., Kim, H., Jang, H., Sa, J. K., Ko, B.-S., & Chang, J. W. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin26108 · Cited by 1 · see citing works

Diagnosis and therapy of cognitive impairment in chronic cerebral ischemia

Хабиров, Ф. А., Фагимовна, Р. Э., Сергеевна, К. О., & Хайбуллина, Д. Х. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-102 · Cited by 1 · see citing works

Tincr protects against cognitive decline by upregulating MYPT1 mediated phosphorylation of structural protein NM IIA in microglia

Wang, Q., Sun, L., Ma, J., Qiu, A., Cong, G., An, X., Qu, Y., Zhang, M., Wang, X., Zeng, L., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03560-x · Cited by 1 · see citing works

A Novel Mouse Model of Mixed Dementia Using Chronic Cerebral Hypoperfusion Induced by Bilateral Carotid Artery Stenosis

Kim, J. H., Kang, H. Y., Park, S. Y., Yang, Y. M., Jo, S., Geum, D., Kim, J., & Park, D. (2025) · Journal of Korean Medical Science · doi:10.3346/jkms.2025.40.e236 · Cited by 1 · see citing works

Hemodynamics in Alzheimer’s Disease and Vascular Cognitive Impairment and Dementia

Cambronero, F. E., & Jefferson, A. L. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190634230.003.0014 · Cited by 1 · see citing works

P4‐017: CHRONIC CEREBRAL HYPOPERFUSION INDUCES TAU HYPERPHOSPHORYLATION ACCOMPANIED BY AXONAL DAMAGE IN ADULT MICE

Fujita, Y., Hamano, T., Shirafuji, N., & Nakamoto, Y. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.1531 · Cited by 1 · see citing works

P3‐286: Hypoperfusion‐Induced TAU Hyperphosphorylation Extends to the Non‐Hypoperfused Area in Mouse Brain

Fujita, Y., Hamano, T., Shirafuji, N., & Nakamoto, Y. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.1950

Chronic cerebral hypoperfusion promotes the propagation of tau pathology through AEP‐I 2 PP2A pathway

Zhang, X. X., Zhong, S., Zhao, S., Jia, S., Yan, Y., Chen, Y., & Zhang, B. (2025) · Alzheimer s & Dementia · doi:10.1002/alz70855_101964

Oligemic Hypoperfusion Differentially Affects Tau and Amyloid-β

Koike, M. A., Green, K. N., Blurton-Jones, M., & LaFerla, F. M. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090750 · Cited by 130 · see citing works

Chronic cerebral hypoperfusion causes decrease of O-GlcNAcylation, hyperphosphorylation of tau and behavioral deficits in mice

Yang, Z., Gu, J., Dai, C., Liu, Q., Iqbal, K., Liu, F., & Gong, C. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00010 · Cited by 100 · see citing works